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1 Summary 
1.1 English 
The protein complex ‘Rad9-Rad1-Hus1’ (‘9-1-1 complex’) is a part of the cell 
machinery to detect DNA lesions. It has been shown to interact with DNA 
polymerase β (Pol β) and other proteins.  
An interaction of the 9-1-1 complex with DNA ligase I could be shown by 
nickel-pulldown-assays with DNA ligase I and 9-1-1 complex. The interaction 
between Pol β and the 9-1-1 complex was investigated more closely by using three 
deletion constructs of Pol β. Immunoprecipitation assays, in vitro polymerase assays, 
in vitro polymerase stimulation assays and electrophoresis mobility shift assays 
indicated that the interaction of the 9-1-1 complex with Pol β is mediated by more 
than one interacting motif. Furthermore the importance of the lyase domain of Pol β 
for its affinity to DNA templates was revealed. Moreover, a sequence alignment with 
known interaction partners of the 9-1-1 complex resulted in the finding of 3 well 
conserved domains. Also the existence of these domains on apurinic endonuclease 1 
showed another potential interaction partner. Structural analysis showed the putative 
binding motifs to be located on the outer surface of all the tested proteins.  
In summary, the results obtained firstly support the hypothesis that the 9-1-1 
complex acts as a recruiting platform for proteins involved in long patch base excision 
repair and secondly propose the existence of 3 interaction motifs forming an 
interaction site for the 9-1-1 complex with its partners.  
 
1.2 German 
 Der Proteinkomplex ‘Rad9-Rad1-Hus1’ (‘9-1-1 Komplex’) ist ein Teil der 
Maschinerie, die in einer Zelle DNA Schäden entdeckt. Es ist bekannt, dass der 9-1-1 
Komplex mit DNA polymerase β (Pol β) und anderen Reparaturproteinen interagiert. 
Eine Interaktion zwischen dem 9-1-1 Komplex und DNA ligase I konnte durch 
Nickel-pulldown-assays von gereinigtem Protein gezeigt werden. Des weiteren wurde 
die schon bekannte Interaktion vom 9-1-1 complex mit Pol β und drei deren 
Deletionsmutanten genauer untersucht. Die Resultate aus Immunopräzipitation 
Experimenten, in vitro polymerase Experimenten, in vitro polymerase stimulation 
Experimenten and “electrophoresis mobility shift” Experimenten zeigten, dass die 
Interaktion des 9-1-1 Komplexes mit Pol β durch mehr als eine Domäne vermittelt  
wird. Des weiteren konnte die Relevanz der Lyase-Domäne auf Pol β für die Bindung 
an die DNA ermittelt werden. Durch Sequenzvergleiche mit bekannten 
Interaktionspartnern des 9-1-1 Komplexes konnten 3 gut konservierte Domänen 
gefunden werden. Da diese Domänen auch auf der “apurinischen Endonuclease 1” 
existieren, stellt dieses Protein ein weiterer möglicher Interaktionspartner dar. 
Strukturanalysen der möglichen Bindungsdomänen zeigten, dass alle 3 davon auf der 
äusseren Oberfläche der getesteten Proteine zu finden sind. 
 Zusammenfassend unterstützen die Resultate erstens die Hypothese, dass der 
9-1-1 Komplex als Rekrutierungsplattform für Proteine dient, die in der “Long patch” 
Basen Exzisionsreparatur involviert sind, und zweitens deuten sie auf die Existenz 
von 3 Bindungsdomänen hin, die die Bindung des 9-1-1 Komplexes mit seinen 
Interaktionspartnern formen.  
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2 Introduction 
 
2.1 DNA stability, the cell cycle and DNA damage checkpoints 
 
All the genetic information that enables a cell to develop, divide and react to its 
environment (shortly said to live) is stored on the DNA located in the cell nucleus. 
DNA, as a chemically highly reactive molecule, is a main target for various kinds of 
damaging agents. Risk factors that can cause severe damage to the DNA are not only 
derived from the cell environment, such as chemical and physical influences, but can 
also consist of intracellular metabolic intermediates such as oxygen, which can 
damage DNA. Finally, DNA polymerisation by DNA polymerases, which can 
accidentally misincorporate nucleotides during DNA replication [1] can lead to 
altered DNA. All these events can cause DNA damages that then may lead to 
incorrect DNA sequence or structure, representing a high risk situation to the cell. 
To guarantee survival, a cell has to be able to replicate its DNA correctly or to 
repair eventual damage, in order to maintain the sequence and structure of this crucial 
molecule stable and active in physiological ranges over the entire lifespan. Over 
billions of years of evolution many different strategies have evolved in order to make 
a cell able to respond to those two tasks of replication and repair in the most efficient 
way possible. Only the most successful strategies have been conserved over this vast 
timespan by being constantly inherited to the subsequent cell generations. Those 
strategies mainly consist of enormous protein machineries coordinating the 
fundamental and complicated events that occur during a cell’s life. It is striking, that, 
despite the evolutionary distance, the functions of those proteins and their underlying 
mechanisms are highly similar in all three kingdoms of life (prokaryotes, archaeas and 
eukaryotes) [2].  
Furthermore, in an organism consisting of more than one cell, an additional task 
to be faced is the communication and coordination of the single cells, in order to 
create a symbiotically functioning complex in which the advantages for the whole 
complex are of higher interest than the fate of a single member. The loss of the ability 
of the cell to act as part of a major complex can lead to severe disorders and problems 
for the whole complex, sometimes resulting in pathological conditions such as cancer 
or hereditary diseases. 
The cell life consists of a cycle, divided in 4 phases: the G1-phase (gap 1) as the 
phase of the cells normal activity state, followed by the S-phase (synthesis), 
representing the period in which the DNA is copied. Afterwards, cell enters the G2-
phase (gap 2), a short phase to enable preparation and initiation of cell division, and 
finally the M-phase (mitosis), which can be subdivided again in different stages, 
where the cell divides itself in 2 identical daughter cells. As a fifth stage the G0-phase 
(gap 0), a steady equivalent of the G1-phase, represents the state of the cells that have 
undergone full differentiation and cannot divide further under normal circumstances.  
The cell cycle progression is strongly regulated and surveyed by so called cell 
cycle checkpoints. By means of highly sophisticated pathways that can be activated at 
those checkpoints, the cell surveys the progression of every phase of the cell cycle, 
even under severe circumstances. The cellular response provoked by DNA damage 
consists of slowing down the cell cycle and stalling it completely at the G2/M 
transition (reviewed in [3]), to provide the necessary time to repair damage through 
multiple different DNA repair mechanisms (reviewed in [4]). Those mechanisms 
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include base excision repair (BER), nucleotide excision repair (NER), mismatch 
repair (MMR) and double-strand break repair (DSBR). One of the main DNA 
polymerases involved in DNA repair is the DNA polymerase β, one of the main 
subjects in this thesis. In addition to this, among many other proteins important for 
DNA replication and repair, DNA ligase I is needed to ligate a freshly synthesized 
DNA strand to the pre-existing downstream strand, in order to guarantee a single, 
coherent new strand to be formed. DNA ligase I is the second protein which was 
looked more closely at in this thesis. 
The DNA damage checkpoint (reviewed in [5] and [6]) is a signal transduction 
pathway, which, in case of DNA damage, either slows down the rate at which S phase 
proceeds or blocks the cell cycle progression completely. It acts as a surveillance 
mechanism that is not required for cell cycle events occurring in physiological 
conditions. However, after extensive damage of the DNA, the maintenance of the 
right order of events that take place in the cell cycle is critically threatened, as the cell 
tends to progress, even though not all the genome has been correctly replicated or 
errors remain unrepaired. This is the point where DNA damage checkpoints play a 
crucial role, in order to ensure that the order of the cell cycle events is maintained 
chronologically correct. Furthermore, the checkpoint pathway targets the induction of 
transcription of genes involved in repair processes as well as stabilisation of stalled 
replication forks and, in worst case, the induction of apoptosis, when integrity of the 
genome cannot be ensured anymore.  
The checkpoint proteins can be divided into several groups.: 
1. The phosphatindylinositol-3-kinase (PI3K)-like protein kinases which form a 
large group and can be further divided into two subgroups; one of them consists of 
large protein kinases named ATM (ataxia telangiectasia mutated) and the other of 
protein kinases called ATR (ataxia- and Rad-related). Both subgroups are thought to 
bind to damaged DNA and either one, the other or both are required for each of the 
DNA-damage-responsive checkpoints.  
2. The PCNA-like group, which is a complex of Rad9, Rad1 and Hus1, forming 
a heterotrimer called the ‘9-1-1’ complex, that can be loaded directly on the DNA at 
sites of DNA damage. This protein complex, representing the third protein-
protagonist in this thesis work, was identified to be involved in the checkpoint 
cascade (al-Khodairy et al., 1994). 
3. Further groups consist of the two serine/threonine (S/T)-kinases Chk1 and 
Chk2 and their adaptor proteins. Those are activated by ATM/ATR and phosphorylate 
targets of the checkpoint. 
 
  
2.2 DNA ligase I 
 
2.2.1 Structure and function of DNA ligase I  
 
DNA ligases play a vital role in the important processes of DNA replication, 
recombination and repair. Their task is to catalyze the joining of breaks in the 
phosphodiester backbone of duplex DNA (either due to a cutting and polymerisation 
step or damage). Three related classes of ATP-dependent DNA ligases have been 
shown to exist in eukaryotic cells - DNA ligases I, III and IV (reviewed in [7] and 
[8]). One of those ATP-dependent ligases is DNA ligase I (molecular mass, 102 kDa), 
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which is required for the ligation of Okazaki fragments during lagging-strand DNA 
synthesis as well as for several DNA-repair pathways. In DNA synthesis, the main 
mediator between DNA ligase I and its DNA substrate is the sliding-clamp protein 
PCNA (proliferating cell nuclear antigen) [9], which is known to bind to DNA 
polymerase δ [10] and thus to be a DNA polymerase processivity factor, probably due 
to a role as coordinator of protein-protein interactions on DNA (reviewed in [11]). 
DNA ligase I consists of 4 domains. Motif I includes the lysine residue as 
catalytic domain (CD) that is adenylated in the first step of the ligation reaction. Motif 
II is a non-catalytic domain (NCD) of unknown function. In addition to the CD and 
NCD domains, DNA ligase I also possesses an amino-terminal domain that includes a 
nuclear localization sequence (NLS) and, at the extreme amino terminus, a conserved 
PCNA-binding motif (PBM). 
 
 
2.2.2 DNA ligase I in DNA repair processes 
 
DNA ligase I is, in addition to its other functions, required for base excision 
repair (BER) (rewiewed in [7, 8]). This is a repair pathway in which a damaged base 
is removed from the DNA, leaving behind an abasic site. After incision of the strand 
(by APE1), removal of the 5’overhang (by Fen1) and polymerization of the 
nucleotides according to the template (by DNA polymerase β), the gap is finally 
sealed again by DNA ligase I. The first step in the ligation reaction catalysed by DNA 
ligase I is the formation of a covalent enzyme-AMP complex. ATP, needed as a 
cofactor in this reaction, is cleaved to pyrophosphate and AMP. Subsequently, the 
AMP is covalently joined to a highly conserved lysine residue in the active site of the 
ligase. The AMP residue, activated by this binding, is then transferred to the 5' 
phosphate of the nick. After this transfer, the nick is sealed by phosphodiester-bond 
formation and release of the AMP. 
 
 
2.3 DNA polymerase β   
 
2.3.1 Structure and function of DNA polymerase β  
 
DNA polymerases (reviewed in [10]) are template-directed enzymes, catalyzing 
phosphoryl transfer reactions. Their role lies in synthesis of long polymers of 
nucleoside monophosphates, whose linear addition is given by the sequence of the 
complementary template DNA strand [12]. The structure of DNA polymerases has 
been optimized through evolution to suit the specialized tasks that each polymerase 
faces within its environment. Among the about 20 DNA polymerases known in an 
animal cell, the one that draws the attention in this thesis work is the DNA 
polymerase β. 
DNA polymerase β is the smallest eukaryotic polymerase. It consists of a single 
39 kDa polypeptide containing 335 amino acid residues (reviewed in [13]) and can be 
divided into two major domains. The small domain is the 8-kDa N-terminal domain, 
that performs the 5'-deoxyribose phosphatase activity (5’dRP-lyase activity) and 
binds single-stranded DNA. The larger 31-kDa domain performs the polymerisation 
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of desoxyribonucleotides to a primer template. This second, large domain can be 
divided further in 3 subdomains: the thumb, the palm and the finger subdomains. 
Those subdomains fold into a conformation resembling a human right hand composed 
of three distinct domains designated as palm, thumb, and fingers. The fingers are 
involved in the process of correctly positioning the template and the incoming 
complementary dNTP, whereas the thumb is important in DNA binding and 
processivity [13, 14]. The structure of DNA polymerase β has been solved by X-ray 
crystallography [15, 16].  
 
 
2.3.2 DNA polymerase β in DNA repair processes 
 
After DNA lesions have occurred, they are immediately recognized by DNA 
damage sensors and transducers [6]. The lesions are then processed by specialized 
multiprotein complexes, that lead to DNA repair via one of the repair pathways such 
as base excision repair (BER), nucleotide excision repair (NER), double-strand break 
repair (DSBR) or mismatch repair (MMR). An important component of these 
complexes are DNA polymerases that have the task to synthesize DNA during the 
DNA repair processes. In human cells, one member of the DNA polymerase X 
family, DNA polymerase β, has been shown to be the major repair polymerase and to 
be essential for the BER pathway. DNA polymerase β’s preferential DNA substrate is 
a shortly gapped DNA substrate [10], on which it performs strand displacement 
synthesis [17]. It also possesses a 5’dRP lyase activity, which is essential for 
completion of BER [18-20]. Furthermore, it has been shown that DNA polymerase β 
is able to bypass in vitro several types of DNA lesions like apurinic (AP) sites, 
cisplatin (cis-Pt) adducts or cyclobutane pyrimidine dimer (CPD) lesions, though it 
displays a relatively low efficiency [21-24]. 
 
 
2.4 The Rad9-Rad1-Hus1 complex: Structure and function 
 
To achieve activation of the cell cycle checkpoints in order to stop cell cycle 
progression due to DNA damage in eukaryotic cells, a wide variety of DNA damage 
sensors and transducers are needed. Some of those are ATM, ATR, ATRIP, Rad17, 
Rad9, Rad1 and Hus1 [6]. The three human proteins Rad9, Rad1 and Hus1 have been 
shown to form a heterotrimeric complex, called the 9-1-1 complex. The structure of 
this complex shares an obvious similarity with the homotrimeric clamp formed by 
proliferating cell nuclear antigen (PCNA) [25-28]. It was further shown, that the 9-1-1 
complex can be loaded on the DNA by human Rad17-RF-C2-5, thus functioning as 
clamp/clamp loader pair, as PCNA is loaded onto DNA by RF-C [29-32]. Further data 
suggests, that upon recognition of DNA lesions by Rad17-RF-C2-5, the 9-1-1 complex 
is recruited to those sites, probably serving as a recruiting platform for the checkpoint 
effector kinases, such as Chk1 or Chk2 [33, 34]. The currently accepted model 
proposes, that the 9-1-1 complex is present where DNA repair is occurring, 
suggesting, that it may play a direct role in subsequent stages of repair processes. The 
fact that the 9-1-1 complex interacts physically and functionally with DNA 
polymerase β [35] and Fen1 [36], strengthens this model further specially considering 
that both proteins play vital roles in DNA repair processes.  
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3 Aim and Project description 
 
Although both DNA repair and DNA damage checkpoint mechanisms are 
quite well known, the link between those two processes induced upon DNA damage 
remains unclear. However, some recent evidence indicated that the 9-1-1 complex 
acting as recruiting platform could play a direct role in subsequent stages of DNA 
repair. Studies with the aim to address the link between checkpoint proteins and DNA 
repair in terms of physical and functional interaction revealed that the 9-1-1 complex 
directly interacts with DNA polymerase β and stimulates its activity. Previous results 
from the Institute of Veterinary Biochemistry and Molecular Biology showed that 
(results published in [35]): 
 
- DNA polymerase β interacts physically with the 9-1-1 complex and each of its 
subunits 
- The 9-1-1 complex specifically stimulates DNA polymerase β by increasing 
its affinity for the primer/template 
- The 9-1-1 complex stimulates the strand displacement synthesis of DNA 
polymerase β 
 
Furthermore, DNA ligase I is involved in DNA repair in terms of being 
responsible for the last step of this process. It ligates the newly synthesised, repaired 
strand to the non-damaged remaining DNA in order to produce one single, coherent 
strand again [7, 8]. The interaction of the 9-1-1 complex with various enzymes 
involved in the DNA repair mechanism (Table 1) as well as the interaction with Fen 1 
[36] and DNA polymerase β [35] has already been shown. Hence it was of great 
interest to study as well the possible interaction of the 9-1-1 complex with DNA 
ligase I, specially considering that 9-1-1 complex is proposed to be the recruiting 
platform for proteins involved in long patch base excision repair (LP-BER).  
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Table 1 was published in [36] and is shown here as slightly modified version. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 1: Functional consequences of the interactions of the two clamps PCNA and 9-1-1 
complex with components of the LP-BER machinery.  
 
 
In a first part of this thesis the physical interaction of the 9-1-1 complex with 
the human DNA ligase I was investigated. This interaction study was done by use of 
Pulldown assays. The assay had first to be optimized for the DNA ligase I protein and 
then tested for possible interaction with the 9-1-1 complex. Those results were 
published in Smirnova et al. [45]. 
LP-BER component Interacting clamp Functional consequence Reference 
DNA glycosylase PCNA 
Enhancement of base excision 
activity 
[37, 38] 
MutY DNA glycosylase 9-1-1 complex Not determined [39] 
Apn2 PCNA 
Stimulation of 3' 5' exonuclease 
and 3'-phosphodiesterase activities 
[40] 
HAP1 9-1-1 complex Not tested Not tested 
DNA polymerase β PCNA No effect [41] 
DNA polymerase β 9-1-1 complex 
Stimulation of polymerase and 
strand displacement activities 
[35] 
Fen1 PCNA 
Stimulation of endo- and exo-
nuclease activities 
[42] 
Fen1 9-1-1 complex 
Stimulation of endo- and exo-
nuclease activities 
[43] 
DNA ligase I PCNA Stimulation of ligase activity [44] 
DNA ligase I 9-1-1 complex Results presented in this work [45] 
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In the second part of this thesis the interaction site of DNA polymerase β with 
the 9-1-1 complex was mapped. This was done by Immunoprecipitation-assays, using 
three DNA polymerase β deletion constructs provided by Nazim El Andaloussi 
(described in [46]). The main part of this thesis work is based on those 3 deletion 
mutants. The mutants were deprived of special domains of wild type protein, called 
lyase, thumb or palm domain, respectively, offering the possibility to study the 
influence of those mutations on their activity, and draw possible conclusions about the 
functions of each of the domains. Furthermore, they enabled more specified 
interaction studies to be performed. These results aimed to contribute to better 
understanding of how the interaction between the 9-1-1 complex and DNA 
polymerase β occurs and how the 9-1-1 complex modulates the activity of DNA 
polymerase β. The first task for this part was to establish and optimize the 
Immunoprecipitation assay for DNA polymerase β full length and the His-tagged 9-1-
1 complex. After this the deletion mutants were tested for their possible interaction 
with the His-9-1-1 complex in the same conditions, to determine the subdomain of 
DNA polymerase β involved in this interaction. Furthermore, in vitro DNA 
polymerase assays and electrophoresis mobility shift assays were carried out to 
investigate changes in DNA polymerisation activity or DNA binding ability of all the 
mutant proteins. The influence of the 9-1-1 complex on those activities was tested as 
well. As a last step some sequence and structure analysis was performed, resulting in 
the finding of three possible 9-1-1 complex interaction motifs on its binding partners. 
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4 Material and Methods 
4.1 Buffers and Solutions 
 
 
Buffer A Buffer B 
(Pol! purification) (Pol! purification)
27.7 mM KCl 1 M KCl
80.2 mM K2HPO4 80.2 mM K2HPO4
20 mM KH2PO4 20 mM KH2PO4
350 mM NaCl 350 mM NaCl
20% (v/v) glycerol 20% (v/v) glycerol 
0.05% (v/v) NP-40 0.05% (v/v) NP-40 
1 mM PMSF 1 mM PMSF
1 mM DTT 1 mM DTT
1 µg/ml pepstatin 1 µg/ml pepstatin
1 µg/ml bestatin 1 µg/ml bestatin
1 µg/ml leupeptin 1 µg/ml leupeptin
Buffer H ‘0’ Buffer H ‘1’ 
(His- & notag 9-1-1 purification) (His- & notag 9-1-1 purification)
25 mM HEPES pH 8.1 1 M NaCl
1 mM EDTA 25 mM HEPES pH 8.1
8.7% (v/v) glycerol 1 mM EDTA
0.01% (v/v) NP-40 8.7% (v/v) glycerol
10 mM !-mercaptoethanol 0.01% (v/v) NP-40
1 mM PMSF 10 mM !-mercaptoethanol
20 µg/ml leupeptin 1 mM PMSF
20 µg/ml leupeptin
Buffer H ‘A’ 
(His-9-1-1 purification) Buffer H ‘B’ 
(His-9-1-1 purification)
100 mM NaCl
25 mM HEPES pH 8.1 300 mM imidazole
1 mM EDTA 100 mM NaCl
8.7% (v/v) glycerol 25 mM HEPES pH 8.1
0.01% (v/v) NP-40 1 mM EDTA
10 mM !-mercaptoethanol 8.7% (v/v) glycerol 
1 mM PMSF 0.01% (v/v) NP-40
20 µg/ml leupeptin 10 mM !-mercaptoethanol
1 mM PMSF
20 µg/ml leupeptin
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Coomassie destaining solution Coomassie staining solution
10% (v/v) acetic acid
10% (v/v) isopropanol 10% (v/v) acetic acid
0.25% (w/v) Coomassie Blue R250
Dialysis buffer 40% (v/v) methanol
(Pol! purification)
Dialysis buffer ‘9-1-1’
20 mM Tris pH 7.5
20% (v/v) glycerol 17.4 % (v/v) glycerol
1 mM !-Mercaptoethanol 100 mM NaCl
100 mM NaCl 20 mM HEPES  pH 8.1
1 mM EDTA
Elution buffer 10 mM !-mercaptoethanol
(Pol! &  His-9-1-1 purification) 1 mM PMSF
20 µg/ml leupeptin
2.7 mM KCl
80.2 mM K2HPO4 EMSA-buffer
20 mM KH2PO4
10% (v/v) glycerol 50!mM Tris–HCl pH 8.0
500 mM Imidazole 10!mM NaCl
0.05% (v/v) NP-40 5!mM EDTA
1 mM PMSF 100!µg/ml bovine serum albumin
1 mM DTT 4% (w/v) Ficoll
1 µg/ml pepstatin 50 fmol of labelled EMSA substrate
1 µg/ml bestatin
1 µg/ml leupeptin Extraction buffer 
(Pol! purification)
IP buffer
2.7 mM KCl
50 mM Tris pH 8 80.2 mM K2HPO4
100 mM NaCl 20 mM KH2PO4
0.05% (v/v) NP-40 350 mM NaCl
1 mM PMSF 10% (v/v) glycerol
1 µg/ml leupeptin 10 mM Imidazol
1 µg/ml pepstatin 0.05% (v/v) NP-40
1 µg/ml bestatin 1 mM PMSF
1 µg/ml pepstatin
1 µg/ml bestatin
1 µg/ml leupeptin
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IP washing buffer Lämmli buffer (2 x)
50 mM Tris pH 8 500 mM Tris pH 7.5
100 mM NaCl 4% (w/v) SDS
0.05% (v/v) NP-40 20% (v/v) glycerol
1 mM PMSF 40 mM DTT
1 µg/ml leupeptin 0.02% (w/v) bromophenol blue
1 µg/ml pepstatin pH 7.5
1 µg/ml bestatin
5 mM imidazole Pulldown buffer
Lysis buffer 50 mM Tris pH 8
(9-1-1 purification) 100 mM NaCl
0.05% (v/v) NP-40
0.5% (v/v) NP-40 1 mM PMSF
50 mM Tris pH 8 1 µg/ml leupeptin
150 mM NaCl 1 µg/ml pepstatin
1 mM EDTA 1 µg/ml bestatin
8.7 % (v/v) glycerol
10 mM !-mercaptoethanol TBE buffer (10 x)
1 mM PMSF
20 µg/ml leupeptin 90 mM Tris
90 mM boric acid
Stop buffer (2 x) 20 mM EDTA
96% (v/v) formamide TBS
20 mM EDTA 
bromophenol blue 10 mM Tris pH 8
xylene cyanol 50 mM NaCl
Pulldown washing buffer TBS-T
50 mM Tris pH 8 10 mM Tris pH 8
100 mM NaCl 50 mM NaCl
0.05% (v/v) NP-40 0.1% (v/v) Tween
1 mM PMSF
1 µg/ml leupeptin Running buffer (SDS-PAGE)
1 µg/ml pepstatin
1 µg/ml bestatin 1.5 M Tris pH 8
5 mM imidazole 0.4% (w/v) SDS
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4.2 Proteins 
 
4.2.1 DNA polymerase β wild type 
 
The DNA polymerase β wild type protein was cloned, transfected, expressed 
and purified by Nazim El Andaloussi [46], according to his protocol.  
 
4.2.2 DNA polymerase β delta lyase 
 
The DNA polymerase β delta lyase protein was cloned, transfected, expressed 
and purified by Nazim El Andaloussi [46]. 
 
4.2.3 DNA polymerase β delta thumb 
 
The DNA polymerase β delta thumb protein was cloned by Nazim El 
Andaloussi [46].  
The purification of the protein was then performed as following. The cell pellet 
from 1 l culture was resuspended in 30 ml extraction buffer and then lysed by 
compressing them twice in the French Press. The lysate was centrifuged 30 min at 
20’000 rpm at +4°C and the supernatant was loaded on a Ni-NTA HiTrap column 
previously equilibrated with degassed washing buffer and degassed elution buffer. 
The flow-through was collected and reloaded later on. After washing the column with 
5 column volumes (column volume = 1 ml) of washing buffer, the elution from the 
Ni-NTA HiTrap column was performed by using a continuous gradient from the 
washing buffer to the elution buffer (10 – 500 mM imidazole) in 10 column volumes, 
collecting fractions of 250 µl volume. Then the column was washed once again with 5 
column volumes of elution buffer to elute eventually retained protein from the 
Washing buffer Transfer buffer
(Pol! &  His-9-1-1 purification)
25 mM Tris-Base
2.7 mM KCl 192 mM glycine
80.2 mM K2HPO4 20% (v/v) methanol
20 mM KH2PO4
10% (v/v) glycerol 5 x annealing buffer 
10 mM Imidazole
0.05% (v/v) NP-40 100 mM Tris pH 7.4
1 mM PMSF 750 mM NaCl
1 mM DTT
1 µg/ml pepstatin
1 µg/ml bestatin
1 µg/ml leupeptin
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column. After this first elution, the flow-through was loaded and eluted according to 
the same procedure. 
To determine the fractions to be pooled and loaded on the next column, 10 µl of every 
third fraction was loaded on a 12 % SDS-PAGE gel [Acrylamide/Bis, solution 
(37.5:1), 40% (w/v) (Serva)]. The gel was stained then by Coomassie staining solution 
for 45 min and destained by washing 3 times 30 minutes with Destaining solution. 
The same was done for the flow-through-elution pools. The eluted samples were then 
pooled according to the Coomassie-gel and the new pools were diluted 1:10 in Buffer 
A to reduce the imidazole concentration in the solution. The first elution pool was 
then loaded on a Hi-trap SP column, previously equilibrated with degassed buffer A 
and degassed buffer B, and eluted using the same elution profile as for the previous 
column (0 – 1 M NaCl). The flowthrough was collected, reloaded together with the 
second elution pool from the first column and eluted after the same scheme. A 12 % 
SDS-PAGE gel was loaded with various fractions from the elution and analysed by 
Coomassie staining and Destaining as described above. The samples containing the 
protein were pooled into 3 different pools (High, Low1, Low2) and dialysed in 
dialysis cassettes (Slide-A-lyzer10K, Pierce) against 3 x 700 ml of Dialysis buffer. 
They were aliquoted by making “Popcorn” in liquid nitrogen and stored in liquid 
nitrogen. 
 
4.2.4 DNA polymerase β delta palm thumb 
 
The DNA polymerase β delta palm delta thumb protein was cloned, 
transfected, expressed and purified by Nazim El Andaloussi [46]. 
 
4.2.5 The untagged ‘9-1-1’ complex  
 
The purification of the human Rad9-Rad1-Hus1 complex (‘9-1-1 complex’) 
was done following a slightly modified protocol from Shiomi et al. [26]. The human 
9-1-1 complex in its native form was expressed by co-expression of baculoviruses 
containing human Rad9, Hus1 and Rad1 cDNA sequences (provided by T. Tsurimoto, 
Japan) in insect SF-21 cells. Fractions containing equivalent amounts of these three 
proteins from insect cell lysates were obtained. The purification was performed by use 
of 3 different columns. The first column consisted of DEAE (=Diethylaminoethyl) 
Sepharose  (Amersham Pharmacia Biotech), as second column a Hitrap Q was used 
and the third was a Hitrap SP. 72 h after infection, 1 x 108 infected SF-21 insect cells 
were lysed in 10 ml lysis buffer at 0°C for 30 min. The lysate was then centrifuged at 
20’000 rpm for 2 h at 4°C (using a  SS34 Rotor, RC5C, Sorvall  Instruments) and the 
supernatent was loaded on the DEAE Sepharose column, previously equilibrated with 
degassed buffer H ‘0’ and degassed buffer H ‘1’. The protein was eluted from the 
column by 40% buffer H ‘1’ (= 400 mM NaCl) and collected according to rising 
optical density (O.D = 280 nM). The DEAE-elution was diluted 1:4 in buffer H ‘0’ 
and centrifuged 10 min at +4°C at 10’000 rpm, and the supernatant was loaded on the 
Hitrap Q (column volume = 1 ml) column previously equilibrated as described above 
for the DEAE Sepharose column. The column was washed with 5 column volumes of 
10% buffer H ‘1’ (= 100 mM NaCl). After this, the sample was eluted by a gradient 
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elution from 100 mM NaCl to 800 mM NaCl, followed by a step to 1 M NaCl and 
additional 5 column volumes of 1 M NaCl. Fractions of 500 µl were collected. To 
investigate which fractions to load on the next column, a 10% SDS-PAGE gel was 
run and a Coomassie staining and a western blot was performed with the 
corresponding antibodies for Hus1 (see 4.3.3), Rad1 (see 4.3.4) and Rad9 (see 4.3.2). 
The pool was diluted again in buffer H ‘0’ to achieve a final NaCl concentration of 
about 50 mM. The pool was then loaded again on a Hitrap SP HP column. The elution 
was done by first washing the column with 5 ml (= 5 column volumes) of 5% buffer 
H ‘1’ (50 mM NaCl) and then performing a step elution with 10 column volumes of 
100 % buffer H ‘1’ (1 M NaCl). A 10% SDS-PAGE gel was run and a coomassie 
staining was performed to determine which fractions to pool as the final protein 
sample. The pools were then dialysed in 3 times 500 ml of dialysis buffer ‘9-1-1’, 
aliquoted and kept on –80°C. 
 
 
4.2.6 The His-tagged 9-1-1 complex 
 
The purification of the human Rad9-Rad1-(His)Hus1 complex (‘9-1-1 
complex’, His-tagged) was optimised in our lab. The human 9-1-1 complex in a His-
tagged form was expressed by co-expression of baculoviruses containing human 
Rad9, His-Hus1 and Rad1 cDNA sequences in insect SF-21 cells. Fractions 
containing equivalent amounts of these three proteins from insect cell lysates were 
obtained. 72 h after infection, 1 x 108 infected SF-21 insect cells were lysed in 10 ml 
lysis buffer at 0°C for 30 min. The lysate was then centrifuged at 20’000 rpm for 2 h 
at 4°C (using a  SS34 Rotor, RC5C, Sorvall  Instruments) and the supernatant was 
loaded on a Ni-NTA HiTrap column (Amersham Biosciences), previously 
equilibrated with degassed buffer H ‘A’ and degassed buffer H ‘B’. After washing the 
column with 5 column volumes (column volume = 1 ml) of buffer H ‘A’, the elution 
from the column was performed by using a continuous gradient from buffer H ‘A’ to 
buffer H ‘B’ (0 – 300 mM imidazole) in 10 column volumes. To clean the column of 
eventually still retained protein, the imidazole concentration was kept high for 5 
additional column volumes. To investigate which fractions to load on the next 
column, a 10% SDS-PAGE gel was run and a Coomassie staining and a western blot 
were performed with the corresponding antibodies for Hus-1 (see 4.3.3), Rad1 (see 
4.3.4) and Rad9 (see 4.3.2). The new pool was diluted 1:4 in buffer H ‘0’ and 
centrifuged 10 min at +4°C at 10’000 rpm, and the supernatent was loaded on the 
Hitrap Q (column volume = 1 ml) column previously equilibrated with buffers H ‘0’ 
and’1’. The column was washed with 5 column volumes of 10% buffer H ‘1’ (= 100 
mM NaCl). After this, the sample was eluted by a gradient elution from 100 mM 
NaCl to 800 mM NaCl, followed by a step to 1 M NaCl and additional 5 column 
volumes of 1 M NaCl. Again a 10% SDS-PAGE gel was run and a coomassie staining 
was done to determine which fractions to pool as the final protein sample. The pools 
were then dialysed in 3 times 500 ml of dialysis buffer ‘9-1-1’, aliquoted and kept on 
–80°C. 
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4.2.7 Bovine serum albumin 
 
The BSA used was purchased from New England Biolabs.  
 
4.3 Antibodies 
4.3.1 Anti-DNA polymerase β antibody 
 
The mouse DNA polymerase β specific antibody 18S was purchased from 
Neo Markers. It recognizes the amino acids 140-154 which are present in the wild 
type as well as in all the three mutants (DNA polymerase β delta lyase, DNA 
polymerase β delta thumb, DNA polymerase β delta palm delta thumb). Therefore all 
the Western blots could be performed using the same antibody. 
 
4.3.2 Anti-Rad9 antibody 
 
The hRad9 cDNA was fused to the GST of the vector pGEX 4T-3 
(Pharmacia). The hRad9 protein was mainly insoluble. The protein was purified 
according to the manufacturer's instructions. Antibodies against the recombinant 
protein were raised in rabbit by standard procedures [47]. This antibody was a gift 
from R. Freire (Teneriffe, Spain). 
 
4.3.3 Anti-Hus1 antibody 
 
The hHus1 cDNA (amino acid 1–134) was cloned and fused to the 
hexahistidine tag of the vector pQE-30 (Qiagen). The hHus1 protein was mainly 
insoluble. It was purified according to the manufacturer's instructions. Antibodies 
against the recombinant protein were raised in rabbit by standard procedures [47]. 
This antibody was a gift from R. Freire (Teneriffe, Spain). 
 
4.3.4 Anti-Rad1 antibody 
 
The goat anti-Rad1 antibody (N-18) was purchased from Santa Cruz 
biotechnology. 
 
4.3.5 Secondary antibodies 
 
Anti-Mouse and Anti-Rabbit IgGs were obtained from Amersham 
Biosciences. 
HRP-conjugated donkey anti-goat antibody was from Santa Cruz Biotechnology. 
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4.4 DNA substrates, primers and oligonucleotides 
 
4.4.1 17/73 mer template for DNA polymerase assays 
 
The 17 and 73 mer (primer/template) were chemically synthesized and purified on 
denaturing polyacrylamide gels in the laboratory of Giuseppe Villani (Toulouse, 
France). The sequences are the following: 
 
d73mer:   
 
5’-GATCGGGAGGGTAGGAATATTGAGGATGAAAGGGTTGAGTTGAGTGGA 
GATAGTGGAGGGTAGTATGGTGGATA-3’ 
 
d17mer: 
 
5'-TATCCACCATACTACCC-3’ 
 
4.4.2 Electrophoresis mobility shift assay (EMSA) oligonucleotide 
substrate 
 
The template consists of a 100 mer one nucleotide gapped substrate of d100 mer, d42 
mer (upstream oligonucleotide) and d57 mer (downstream oligonucleotide). 
 
4.5 Nickel-Pulldown of untagged 9-1-1 complex via His-DNA 
ligase I 
 
For detailed Material and Methods, see pulldown experiments in the published 
results in Smirnova et al., 2005 [45], enclosed in this thesis. 
 
4.6 Immunoprecipitation assay of His DNA polymerase β  wild 
type, His DNA polymerase β  delta lyase, His DNA polymerase 
β  delta thumb and His DNA polymerase β  delta palm delta 
thumb by his-9-1-1 complex 
 
3.6 µg (= 154 pmol) of purified His-tagged DNA polymerase β wild type, 4.23 
µg (=154 pmol) of DNA polymerase β delta lyase, 4.65 µg (=154 pmol) of DNA 
polymerase β delta thumb or 2.74 µg (= 154 pmol) of DNA polymerase β delta palm 
delta thumb, respectively, were preincubated with 3.6 µg of purified His-9-1-1 
complex in a final volume of 30 µl in IP-buffer on a roller shaker at +4°C for 2 hours. 
2 µl of anti-Rad9 antibody was added and incubated for 1 h at +4°C. 60 mg of protein 
A sepharose were coated by incubation overnight in 1 ml of IP buffer containing 1 mg 
boiled BSA. After centrifuging 2 min at 1500 rpm at +4°C (centrifuge 5417R, 
Eppendorf), the supernatent was discarded and 1 ml of washing buffer was added. 
This washing procedure was repeated 3 times, every time with 10 min of incubation 
time on the roller shaker at +4°C. Then the beads were resuspended in 500 µl IP 
 Page 20 of 56 
buffer. 40 µl of this equilibrated protein A sepharose beads-slurry was then added to 
the reaction and the reaction was incubated for 1 more hour at +4°C. After washing 
again three times in washing buffer as described above, the supernatant was removed 
and 20 µl Lämmli buffer was added. The co-precipitated proteins were resolved on a 
10% SDS-PAGE gel for 9-1-1 complex or a 12% SDS-PAGE gel for DNA 
polymerase β, respectively, and analyzed by western blot using the corresponding 
antibodies. 
For negative control reactions, anti-Rad9 antibodies were added to a mix with 
DNA polymerase β only, leaving away the 9-1-1 complex. This showed us if a 
unspecific binding of DNA polymerase β to protein A sepharose beads coated with 
anti-Rad9 antibody occurred or not. 
 
 
4.7 Western blot 
 
Proteins were separated on a SDS-PAGE [Acrylamide/Bis, solution (37.5:1), 
40% (w/v) (Serva)] and electroblotted during 1.5 h at 120 V (BioRad Western Blot 
apparatus) onto a PVDF Membrane (Immobilon) in transfer buffer at + 4 °C. After 
blocking the membranes for 45 min in TBS-T with 2.5% powdered Milk, the 
membranes were incubated with the appropriate antibodies, diluted in TBS-T with 
2.5% powdered Milk, for 4 hours at room temperature. Then the membranes were 
washed 3 times 10 minutes in TBS-T and incubated with the corresponding secondary 
antibodies, diluted in TBS-T with 2.5% powdered Milk, for 1 hour. This was 
followed by washing again the membranes 3 times 10 min in TBS-T and additionally 
2 times 5 min in TBS. The antibodies bound to the membranes were then detected by 
Uptilight HRP Blot Chemoluminescent Substrate (Uptima) and exposure to a X-ray 
film (Contatyp, Typon Imaging AG) 
 
 
4.8 Preparation of radiolabeled template 
 
To prepare the 17/73 mer primer template, the 17 mer primer was labeled at its 
5' end by mixing the following reagents in a reaction mix to a final volume of 20 µl: 
 
3.6 mM 17 mer 
20 µCi [γ-32P]dATP (Amersham Biosciences) 
2µl 10 x PNK buffer (New England Biolabs) 
0.6µl T4 polynucleotide kinase (New England Biolabs) 
 
The mix was incubated for 40 min at 37°C and then heat inactivated for 10 min 
at 80°C and centrifuged through a G-25 (Microspin TM) column at 720 x g for 2 min to 
remove the free ATP. The reaction was then added to the annealing mix containing 
following reagents to a final volume of 36 µl: 
 
3.6 mM  73 mer 
7.2 µl 5 x annealing buffer  
 
This mix was then heated at 95°C for 10 min and cooled down overnight slowly 
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to room temperature to allow the primer to anneal to the template.  
The 1 nucleotide gapped substrate was prepared by 5' labeling of the upstream 
42 mer oligonucleotide, followed by annealing of this oligonucleotide with equimolar 
amounts of the 100 mer template and the 57 mer downstream oligonucleotide, 
according to the protocol described above. 
 
 
4.9 DNA polymerase assay 
 
The DNA polymerase reaction was performed in a final volume of 10 µl 
containing: 50 mM Tris pH 7.5, 2.5 mg/ml BSA, 10 mM DTT, 50 µM 5’ labelled 
17*/73 mer, 1 mM MnCl2 and 100 µM dNTP’s (Roche). The reaction was started by 
adding 9 µl of the reaction mix to DNA polymerase β dilutions done in 1 µl and then 
incubated at 37 °C for 15 min. Finally, 10 µl of 2 x Stop buffer was added to each 
reaction tube and the reaction was put on ice. The samples were heated for 3 min at 
95°C and loaded on a 10% denaturing polyacrylamide (Acrylamide/Bis-acrylamide, 
19:1 mixture, 40%  (w/v) (Qbiogene)) sequencing gel containing 7 M urea. The result 
was visualised by exposing the gel to a X-ray film (Contatyp, Typon Imaging AG) 
overnight at –80°C, using a radioactivity-sensitive screen (Okamoto). 
 
 
4.10 DNA polymerase β  stimulation assay by 9-1-1 complex 
 
His-9-1-1 dilutions (amounts as indicated) were done in 1 µl and were 
complemented with BSA, in order to maintain a constant total protein amount in the 
dilutions. 2 µl of 1:1 His-9-1-1/BSA dilutions was preincubated in 6.5 µl of 
preincubation mix consisting of 50 mM Tris pH 7.5, 2.5 mg/ml BSA, 10 mM DTT, 
50 µM 5’ labelled 17*/73 mer and 135 nM DNA polymerase β wild type for 15 min 
on ice. Then 1.5 µl of starting-mix [100 µM dNTP’s (Roche) and 1 mM MnCl2, final 
concentrations] was added and the reaction incubated for 15 additional minutes at 
37°C. The reaction was stopped by adding 10 µl of 2 x Stop buffer and putting the 
samples on ice. The samples were heated for 3 min at 95°C and then loaded on a 10% 
denaturing polyacrylamide (Acrylamide/Bis-acrylamide, 19:1 mixture, 40%  (w/v) 
(Qbiogene)) sequencing gel containing 7 M urea. The result was visualised by 
exposing the gel to a X-ray film (Contatyp, Typon Imaging AG) overnight at –80°C, 
using a radioactivity-sensitive screen (Okamoto). 
 
 
4.11 Electrophoresis mobility shift assay (EMSA) for DNA 
polymerase β  and its deletion mutants 
 
Binding reactions with 50 fmol of 1 nt gap DNA substrate (see Figure 5, panel 
A) were carried out in a total volume of 20 µl in EMSA-buffer using the indicated 
amounts of DNA polymerase β or its mutants (Figure 5, panels B-E). After incubation 
at room temperature for 30 minutes, reactions were loaded on 6% polyacrylamide gels 
containing 0.5x TBE and run first at 50 V for 45 minutes and then at 100 V for 3 
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hours. The bands were visualized by autoradiography. 
 
 
4.12 Alignment-search 
 
The search for possible alignments was done using the ClustalW program from 
the European Bioinformatics Institute. 
http://www.ebi.ac.uk/clustalw/# 
Manufacturers description: “Clustal W is a general purpose multiple sequence 
alignment program for DNA or proteins. It produces biologically meaningful multiple 
sequence alignments of divergent sequences. It calculates the best match for the 
selected sequences, and lines them up so that the identities, similarities and 
differences can be seen. Evolutionary relationships can be seen via viewing 
Cladograms or Phylograms.” The sequences of the proteins used for alignment were 
obtained from the NCBI-website using the entrez-protein database. 
 
 
4.13 Structural models of DNA polymerase β , DNA ligase I 
and apurinic endunuclease I 
 
The structural models were visualized using the program ‘RasMol’, version 
2.7.2.1.1 [48]. The models to use in this program can be found in the “MMDB 
Structure Summary” [49].  
Model of DNA polymerase β: 8ICK; Dna Polymerase Beta (Pol B) (E.C.2.7.7.7) 
Complexed With Seven Base Pairs Of Dna; Soaked In The Presence Of Datp (1 
Millimolar), Mgcl2 (5 Millimolar), And Mncl2 (5 Millimolar) 
Model of DNA ligase I: 1X9N; Crystal Structure Of Human DNA Ligase I 
Bound To 5'- Adenylated, Nicked DNA 
Model of apurinic endonuclease 1 (APE1): 1BIX; The Crystal Structure Of The 
Human DNA Repair Endonuclease Hap1 Suggests The Recognition Of Extra-Helical 
Deoxyribose At DNA Abasic Sites  
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5 Results 
 
5.1 Human DNA ligase I interacts with the 9-1-1 complex 
 
To test the possible interaction between human DNA ligase I and the 9-1-1 
complex, a pulldown assay was performed. After some optimization steps, including 
testing different NaCl and NP-40 conditions, 100 mM NaCl and 0.1 % of NP-40 
showed to be optimal. As an additional control the ‘non-binder’ GST was included. 
The results of this pulldown assay can be viewed in Smirnova et al., 2005, Figure 1, 
enclosed in this thesis under point 8. In the pulldown assay analysis a specific protein-
protein interaction between the 9-1-1 complex and DNA ligase I under the given 
conditions was observed. The 9-1-1 complex was present as a complex, which was 
verified by western blot analysis against Rad9, Rad1 and Hus1. Furthermore, GST did 
not bind to DNA ligase I under these conditions, confirming the specificity of this 
interaction. These data contribute to additionally strengthening the model, that the 9-
1-1 complex might act as a recruiting platform for proteins involved in LP-BER, 
similarly to PCNA in the replication machinery.  
 
 
5.2 Characterization of DNA polymerase β  deletion mutants 
 
The DNA polymerase β and its deletion mutants are schematically presented in 
Figure 1, panel A. The proteins all contain a 6-histidine residue N-terminal tag. The 
DNA polymerase β wild type protein consists of 335 amino acids, of which the 
sequence is displayed in Figure 1, panel B. Its molecular weight is 36 kDa. The DNA 
polymerase β delta lyase mutant lacks the N-terminal part of the wild type DNA 
polymerase β, known as ‘lyase-domain’ (Figure 1, panels A and B). The deletion 
consists of the amino acids 1-101. Thus, the delta lyase protein is composed of the 
remaining amino acids 102-335, with a molecular weight of 27 kDa. The DNA 
polymerase β delta thumb mutant consists of the amino acids 1-262 of the wild type 
DNA polymerase β (Figure 1, panels A and B). It has been deleted of its C-terminal 
part of the amino acids 263-335, also referred to as the thumb domain. The molecular 
weight of this mutant is 29.7 kDa. The DNA polymerase β delta palm thumb mutant 
is deprived of the amino acids 156-335, therefore lacking a big part of the C-terminal 
part of the wild type protein (Figure 1, panels A and B). The deleted part is referred to 
as the thumb and the palm domain of the wild type protein. This mutant has a 
molecular weight of 17.5 kDa. 
In order to check the DNA polymerase β deletion mutants for correct size and 
protein concentration and to rule out eventual contamination of the batches by other 
proteins, 12% SDS-PAGE was loaded with 2 µg of each protein, previously 
resuspended in Lämmli buffer and boiled for 5 minutes at 95°C. The gel was stained 
with Coomassie blue and destained. The result (Figure 2) showed, that the mutant 
batches are clearly free of DNA polymerase β wild type contamination and are of a 
quite high purity. The mutant proteins run in the gels as expected according to their 
molecular weight, which was important to know for the immunoprecipitation – 
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western blots performed later on. DNA polymerase β wild type (polβ WT) showed 
some degradation, probably due to long storage of this aliquot on –20°C.  
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Figure 1: Schematic presentation of DNA polymerase β and its deletion  
mutants used in this thesis. 
(A) Scheme of DNA polymerase β wild type and its deletion mutants. The 
proteins all contain a 6-His-tag on the N-terminal part. The lyase domain is 
present in all of the proteins except in the delta lyase mutant. The full 
polymerase domain is present in the wild type and the delta lyase construct. 
The delta thumb construct has a polymerase domain lacking the last 73 
amino acids on the C-terminal end. The delta palm thumb construct lacks 
180 last C-terminal  amino acids. (B) Sequence of the DNA  polymerase β 
wild type. The small straight arrows indicate the amino acids, which 
surround the truncation sites. The bent arrows show the mutant protein 
remaining, labelled with the names of the mutants. 
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Figure 2: Coomassie staining of DNA polymerase β wild type and its 
deletion constructs. 2 µg of each protein was loaded onto an SDS-PAGE 
gel and separated as outlined in Materials and Methods. Polβ WT = DNA 
polymerase β  wild type, Polβ Δ L = DNA polymerase β delta lyase, Polβ Δ 
T = DNA polynerase β delta thumb, Polβ Δ PT = DNA polymerase β delta 
palm thumb. 
 
 
5.3 DNA polymerase β  wild type interacts with the 9-1-1 
complex 
 
In order to confirm the interaction studies between 9-1-1 complex and DNA 
polymerase β wild type, and to be able to test the deletion mutants of DNA 
polymerase β under optimal conditions, first an Immunoprecipitation assay had to be 
established and optimized. For this, a NaCl concentration of 100 mM and an amount 
0.05% (v/v) NP-40 was chosen to be the starting conditions, which had proved to be 
suitable to show this interaction experiments and to reflect also physiological 
conditions.  
First, immunoprecipitation of a DNA polymerase β amount of 6 µg and a 9-1-1 
complex amount of 3.6 µg was chosen, using either 2.5 µl or 1 µl of anti-Rad9 
antibody (Figure 1) or 2.5 µl anti-Rad1 antibody (data not shown), to see which 
amounts of antibody and which one of the antibodies worked best. The negative 
controls were either the 9-1-1 complex and DNA polymerase β with preimmuneserum 
(the same amount as anti-Rad9 antibody) or anti-Rad9 antibody and DNA polymerase 
β in the absence of the 9-1-1 complex. From previous work done in this lab, it was 
expected, that the anti-Rad1 antibody was the most efficient for immunoprecipitation 
studies. However, the anti-Rad9 antibody, in addition to recognising specifically 
Rad9, recognises also the heavy chain of antibodies. Unfortunately Rad9 and heavy 
chains are both running at the same size, which makes it impossible to visualise Rad9 
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by a western blot against Rad9 protein after immunoprecipitation. For this reason 
DNA polymerase β was preferably immunoprecipitated by the anti-Rad9 antibody, in 
order to be able to show that all the three proteins of the 9-1-1 complex were present. 
Anti-Hus1 had been shown to be the least effective antibody for those interaction 
studies. For this and the same reason as for anti-Rad1 antibody, the antibody to be 
preferred was in any case the anti-Rad9. The result (Figure 3) showed, that the anti-
Rad9 antibody could well be used in our studies, even with only 1 µl per assay. Under 
both conditions DNA polymerase β was co-immunoprecipitated by the 9-1-1 complex 
bound to protein-A sepharose beads via the anti-Rad9 antibody, but did clearly not 
bind to the beads either via the 9-1-1 complex and preimmuneserum or via anti-Rad9 
antibody in the absence of the 9-1-1 complex (Figure 3, panel A). Furthermore, the 
best and most important negative control proved to be the one with anti-Rad9 
antibody, no 9-1-1 complex and DNA polymerase β, as this could show clearly, if any 
of the DNA polymerase β bound to the beads unspecifically via affinity to the anti-
Rad9 antibody. This control was then chosen for all subsequent experiments. In 
addition panel B and C in Figure 2 show that the entire 9-1-1 complex was 
precipitated by the anti-Rad9 antibody, since Rad1 and Hus1 could be detected in the 
immunoprecipitation as well. 
It was furthermore of interest to test a reduced amount of DNA polymerase β, 
since the system should not be oversaturated and the aim was to use equimolar 
amounts of DNA polymerase β deletion mutants later. To test this, the amount of 
DNA polymerase β used was reduced to 3.6 µg in parallel with the amount of anti-
Rad9 antibody that was lowered to 2 µl. When these lower amounts of DNA 
polymerase β were used, the DNA polymerase β could still be immunoprecipitated by 
the 9-1-1 complex bound to the protein-A sepharose beads, but not via unspecific 
binding through anti-Rad9 antibody (Figure 4, panel A).  
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Figure 3: Optimization of the immunoprecipitation of the His-9-1-1 
complex and DNA polymerase β wild type. (A) Protein-A sepharose 
immunoprecipitations were performed in the presence of either 2.5 µl or 1 
µl of anti-Rad9 antibody and 3.6 µg 9-1-1 complex and 6 µg DNA 
polymerase β. Negative controls were either 2.5 µl or 1 µl 
preimmuneserum (PreIs) and 3.6 µg 9-1-1 complex and 6 µ DNA 
polymerase β or 2.5 µl or 1 µl of anti-Rad9 antibody with 3.6 µg DNA 
polymerase β only. (B) The presence of Rad1 protein in the 9-1-1 complex 
was tested by analyzing a part of the immunoprecipitation with anti-Rad1 
antibody. (C) The presence of Hus1 protein in the 9-1-1 complex was tested 
by analyzing a part of immunoprecipitation with anti-Hus1 antibody. The 
presence of co-precipitated proteins was determined by SDS-PAGE 
followed by Western blot analysis against the indicated proteins. 
  
 
 
5.4 DNA polymerase β  likely interacts with the 9-1-1 complex 
via its palm domain 
 
To investigate, in which subdomain the 9-1-1 complex binds to pol β, the 
immunoprecipitation assay described was performed with the 3 deletion mutants, 
using the same conditions as for the wild type form of DNA polymerase β. The 
mutants were used in equimolar amounts as the DNA polymerase β wild type, of 
which 3.6 µg was used. The results showed that  
I the DNA polymerase β delta lyase mutant interacts with the 9-1-1 
complex (Figure 4, panel B);  
II the DNA polymerase β delta thumb mutant interacts with the 9-1-1 
complex (Figure 4, panel C);  
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III the DNA polymerase β delta palm delta thumb mutant does not show 
any interaction with the 9-1-1 complex (Figure 4, panel D)  
IV the 9-1-1 complex is always present as a complex, since Rad1 (Figure 
4, panel E) and Hus1 (Figure 4, panel F) were present as co-
immunoprecipitated proteins in all of the 4 different 
immunoprecipitation assays.  
These results suggested, that the domain of pol β which mediates its 
interaction with 9-1-1 complex is most likely the palm domain, as a loss of specific 
interaction between the two proteins could be observed when this part of DNA 
polymerase β was deleted. 
 
 
 
 
 
Figure 4: DNA polymerase β likely interacts with the 9-1-1 complex via its 
palm-domain. Immunoprecipitation of His-DNA polymerase β wild type 
and the His-pol β deletion mutants by His-9-1-1 complex. (A) The 
immunoprecipitation assay was performed in the presence of 2 µl of anti-
Rad9 antibody and 3.6 µg of 9-1-1 complex and 3.6 µg pol β wild type. The 
negative control was done by use of 2 µl of anti-Rad9 antibody with 3.6 µg 
DNA polymerase β only. (B) The immunoprecipitation assay was 
performed in the presence of 2 µl of anti-Rad9 antibody and 3.6 µg of 9-1-
1 complex and 2.5 µg DNA polymerase β delta lyase. The negative control 
was done by use of 2 µl of anti-Rad9 antibody with 2..5 µg of DNA 
polymerase β delta lyase only. (C) Protein-A sepharose 
immunoprecipitation was performed in the presence of either 2 µl of anti-
Rad9 antibody and 3.6 µg of 9-1-1 complex and 2.9 µg of DNA polymerase 
pol β delta thumb. The negative control was done by use of 2 µl of anti-
Rad9 antibody with 2.9 µg of DNA polymerase β delta thumb only. (D) 
Immunoprecipitation was performed in the presence of 2 µl of anti-Rad9 
antibody and 3.6 µg of 9-1-1 complex and 1.65 µg of DNA polymerase β 
delta palm thumb. The negative control was done by use of 2 µl of anti-
Rad9 antibody with 1.65 µg of DNA polymerase β delta palm thumb only. 
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(E) The presence of the Rad1 protein in the 9-1-1 complex was tested by 
analyzing a part of the immunoprecipitation with anti-Rad1 antibody. (F) 
The presence of the Hus1 protein in the 9-1-1 complex was tested by 
analyzing a part of the immunoprecipitation with anti-Hus1 antibody. The 
proteins were detected by SDS-PAGE followed by Western blot (WB) 
analysis against the proteins indicated. 
 
 
5.5 DNA polymerase β  deletion mutants harbour a decreased, 
but still detectable polymerase activity 
 
To be able to later on test the influence of the 9-1-1 complex on the DNA 
polymerase β deletion mutants’ activity, the DNA polymerase β wild type and the 
deletion mutants had first to be tested for their polymerase activity. This was done by 
a titration of the proteins in increasing amounts into the assay. As a DNA template a 
5’labelled 17 mer primer annealed to a 73 mer oligonucleotide was used 
(schematically depicted in Figure 5, panel A). Surprisingly, all of the three mutants 
showed polymerase activity. However, differences in the polymerisation rate between 
the different mutants were observed. The DNA polymerase β delta lyase construct, 
having a completely conserved polymerase domain, but lacking the C-terminal ‘lyase’ 
part, was able to polymerise and accumulate mainly short products of up to 9 
nucleotides in high amounts but was hardly able to elongate the strand completely 
(Figure 5, panel C). The total amount of products accumulated did not seem to be less 
than for the other mutants, but more of the short products accumulated, compensating 
for the lack of complete elongation activity. This suggested that this mutant has a 
strongly reduced processivity, in agreement with other studies on the dRP lyase 
domain [20]. 
In contrast, the DNA polymerase β delta thumb construct, lacking the thumb part of 
its hand-shaped polymerase domain, which enables the polymerase part to close like a 
fist around the DNA, elongated the primer almost completely, suggesting that it did 
not have lost any of its affinity to the DNA substrate (Figure 5, panel D). Already 
with small amounts of this mutant, a complete elongation of the primer could be 
observed, although the amount of synthesised products was much lower than with 
DNA polymerase β wild type (Figure 5, panel B). Similarly to the DNA polymerase β 
delta thumb mutant, also the DNA polymerase β delta palm thumb deletion mutant 
showed to be active without significant loss of DNA binding ability (Figure 5, panel 
E), but it showed an even lower level of activity compared to DNA polymerase β wild 
type. Since the DNA polymerase β delta palm thumb mutant lacks the active site of 
the polymerase catalytic site it should per definition not show any polymerase activity 
on its own. Therefore it is likely that this mutant was contaminated with E. coli DNA 
polymerase(s), probably due to co-purification with the mutant. For this reason the 
mutant was not used for further DNA polymerase activity experiments anymore. 
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Figure 5: The DNA polymerase β deletion mutants display differences in 
polymerase activity compared to the wild type protein. 
(A) DNA-substrate used for the in vitro polymerase activity assays. (B) 
Titration of DNA polymerase β wild type in increasing amounts, using 50 
fmol of DNA-template. No enzyme control (= lane 1) displays the signal 
corresponding to the template alone. Lanes 2-4 contain 0.675, 1.35 and 2.7 
fmol of DNA polymerase β wild type, respectively. (C) Titration of DNA 
polymerase β delta lyase in increasing amounts, using 50 fmol of DNA 
template. Lanes 1-6 contain 0.2, 0.4, 0.8, 1.6, 3.2 and 6.4 nmol of DNA 
polymerase β delta lyase, respectively (D) Titration of DNA polymerase β 
delta thumb in indreasing amounts, using 50 fmol of DNA template. Lanes 
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1-6 contain 0.17, 0.34, 0.68, 1.3, 2.7 and 5.4 nmol of DNA polymerase β 
delta thumb, respectively (E) Titration of DNA polymerase β delta palm 
thumb in increasing amounts, using 50 fmol of DNA template. Lanes 1-5 
contain 0.3, 0.6, 1.2, 2.4 and 4.8 nmol of DNA polymerase β delta palm 
thumb, respectively 
 
5.6 The 9-1-1 complex stimulates the activity of full length 
DNA polymerase β  and of its mutants 
 
To confirm the stimulating effect of the 9-1-1 complex on DNA polymerase β 
and to test possible effect of the 9-1-1 complex on the DNA polymerase β deletion 
mutants, a polymerase stimulation assay was carried out. The template used was the 
same as for the in vitro polymerase assays described in 5.4 (see Figure 5, panel A). 
Appropriate amounts from the linear range of the titrations (Figure 5, panels B-E) 
were chosen to test the effect of the 9-1-1 complex. 1.35 fmol of DNA polymerase β 
wild type was used and a titration of the 9-1-1 complex with increasing molar ratios 
was performed. As controls a constant amount of total protein in the reactions was 
achieved by supplementing with BSA in the according amounts (Figure 6, panel A). 
To rule out an eventual additional polymerase contamination by the 9-1-1 complex, 
the highest amount of 9-1-1 complex used for the titration was added in the absence 
of DNA polymerase β (Figure 6, panel A, lane 9). The molar ratios of 9-1-1 complex : 
DNA polymerase β were then kept the same for the two deletion mutants that were 
tested, but due to the weaker activity, the amounts of DNA polymerase β mutants and 
therefore also of the 9-1-1 complex used had to be higher. For both mutants the 
amount of 34 fmol was used. This represents a 25 fold higher amount than the one 
used for the DNA polymerase β wild type titration with the 9-1-1 complex in Figure 
6, panel A. Furthermore, the ratio range of 9-1-1 complex : DNA polymerase β 
mutants used could not be pushed as high as for the titration with DNA polymerase β 
wild type, as this would have needed again too high amounts of protein. To exclude 
eventual contaminants due to the 9-1-1 complex used in such high amounts for the 
titration with the deletion mutants, a titration with the same amounts of the 9-1-1 
complex in the absence of DNA polymerase β was performed. Even with such high 
amounts of the 9-1-1 complex used, no significant contamination by polymerases or 
nucleases could be detected (data not shown). 
First, the stimulation of the DNA polymerase β wild type, shown already 
previously by work from the Institute of Veterinary Biochemistry and Molecular 
Biology [35], could be confirmed (Figure 5, panel A).  For the DNA polymerase β 
delta lyase mutant (Figure 6, panel B), a clear stimulation by the 9-1-1 complex could 
be observed as well. The fact that it could be stimulated by the 9-1-1 complex was not 
really surprising when considering the data from the interaction studies, but the extent 
in which the loss of affinity to DNA of this mutant (shown in Figure 5, panel C) could 
be compensated by addition of the 9-1-1 complex was striking. By addition of the 9-
1-1 complex the DNA polymerase β delta lyase mutant seems to regain at least 
partially the ability to perform processive polymerisation, leading to full length 
elongation of the DNA template. This result confirms, as shown previously in our 
labarotary [35], that the stimulative effect of the 9-1-1 complex triggers via an 
increase in the binding of the DNA polymerase β to DNA. The delta thumb mutant 
was stimulated by the 9-1-1 complex as well (Figure 6, panel C). The addition of the 
9-1-1 complex appears to promote again an accumulation of full length products. 
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Figure 6: The polymerisation activity of DNA polymerase β wild type and its 
deletion mutants can be stimulated by the 9-1-1 complex. 
(A) Titration of increasing amounts of the 9-1-1 complex, always 
complemented with BSA to reach a constant protein amount within every tube, 
into a constant amount of 1.35 fmol DNA polymerase β wild type. The amounts 
of 9-1-1 complex that were used ranged from 0 to 880 fmol. No enzyme control 
(lane 1) shows the template alone, lane 2 = DNA polymerase β wild type only, 
lanes 3-8 = ratios of 9-1-1 complex : DNA polymerase β wild type 32, 80, 160, 
320, 480 and 640, respectively. Lane 9 = 880 fmol 9-1-1 complex only. (B) 
Titration of increasing amounts of the 9-1-1 complex into a constant amount of 
34 fmol of DNA polymerase β delta lyase. The reactions were always 
complemented with BSA to reach a constant protein amount within every tube. 
The amounts of 9-1-1 complex used ranged from 0 to 2720 fmol. Lane 1 = DNA 
polymerase β delta lyase only, lanes 2-5 = ratios of 9-1-1 complex : DNA 
polymerase β delta lyase 10, 20, 40 and 80, respectively. (C) Titration of 
increasing amounts of the 9-1-1 complex into a constant amount of 34 fmol of 
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DNA polymerase β delta thumb. The reactions were always complemented with 
BSA to reach a constant protein amount within every tube. The amounts of 9-1-
1 complex used ranged from 0 to 2720 fmol. Lane 1 = DNA polymerase β delta 
thumb only, lanes 2-5 = ratios of 9-1-1 complex : DNA polymerase β delta 
thumb 10, 20, 40 and 80, respectively. (D) Negative control for the 9-1-1 
complex in high amounts used as in the titrations for the mutants. The amount 
of the 9-1-1 complex that was used for this negative control corresponds to a 
ratio of 9-1-1 complex : DNA polymerase β mutant of 50. Exposition time like 
for the films for the mutant titrations. This negative control shows, that there is 
not significant polymerase or nuclease contamination in the 9-1-1 complex 
batch. 
 
 
5.7 DNA polymerase β ’s binding to DNA is greatly decreased 
in the absence of the lyase domain 
 
To address the question, whether the reduced processivity of the delta lyase 
mutant might be due to a reduction of its binding ability to DNA, an EMSA 
(Electrophoresis mobility shift assay) using a 1 nucleotide gap oligonucleotide 
(depicted in Figure 7, panel A) was performed with the wild type protein and each of 
the mutants. The DNA polymerase β wild type and its mutants were titrated in 
increasing amounts into the reaction.  
The results revealed, that DNA polymerase β delta thumb (Pol β ΔT, Figure 7, 
panel C) and DNA polymerase β delta palm thumb (Polβ ΔPT, Figure 7, panel E) 
were able to bind to DNA almost equally to DNA polymerase β wild type (Polβ WT, 
Figure 7, panel B) although the observed band shift was slightly weaker when 
comparable amounts of the mutants were used. However, the DNA polymerase β 
delta lyase (Polβ ΔL, Figure 7, panel D) showed a strongly reduced ability to bind to 
DNA. Molar amounts that had to be used for the DNA polymerase β delta lyase 
mutant to see a comparable DNA-bandshift are 150 times higher than the amounts 
used for the DNA polymerase β delta thumb and DNA polymerase β delta palm 
thumb mutants. This result confirms the data obtained in the polymerase assay for the 
DNA polymerase β delta lyase mutant, which was not able to synthesize full length 
products and this is likely due to its reduced DNA binding ability. 
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Figure 7: DNA polymerase β’s binding to DNA is decreased in the absence 
of the lyase domain. An electrophoresis mobility shift assay with 50 fmol of 
1 nt gap DNA substrate and increasing amounts of DNA polymerase β wild 
type and its mutants was performed. (A) 1 nt gap 5’labelled DNA substrate 
used for the EMSA. (B) Titration of DNA polymerase β wild type in 
increasing amounts into the reaction with 50 fmol DNA substrate. The no 
enzyme control is the reaction mix without adding DNA polymerase β. 
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Lanes 1-3: 35, 70 and 140 fmol of DNA polymerase β wild type, 
respectively. The result shows increased affinity of DNA polymerase β wild 
type to the DNA substrate with increasing DNA polymerase β wild type 
amounts used. (C) Titration of DNA polymerase β delta thumb in 
increasing amounts into the reaction with 50 fmol DNA substrate. The no 
enzyme control is the reaction mix without adding DNA polymerase β delta 
thumb. Lanes 1-5: 34, 68, 170, 340 and 680 fmol of DNA polymerase β 
delta thumb, respectively. The result shows increased affinity of DNA 
polymerase β delta thumb to the DNA substrate with increasing DNA 
polymerase β delta thumb amounts used. (D) Titration of DNA polymerase 
β delta lyase in increasing amounts into the reaction with 50 fmol DNA 
substrate. The no enzyme control is the reaction mix without adding DNA 
polymerase β delta lyase. Lanes 1-4: 10, 20, 40 and 80 nmol of DNA 
polymerase β delta lyase, respectively. The result shows increased affinity 
of DNA polymerase β delta lyase to the DNA substrate with increasing 
DNA polymerase β delta lyase amounts used, but also clearly an greatly 
decreased affinity for the DNA template compared to the other DNA 
polymerase β EMSA titrations. (E) Titration of DNA polymerase β delta 
palm thumb in increasing amounts into the reaction with 50 fmol DNA 
substrate. The no enzyme control is the reaction mix without adding DNA 
polymerase β delta palm thumb. Lanes 1-5: 34, 68, 170, 340 and 680 fmol 
of DNA polymerase β delta palm thumb, respectively. The result shows 
increased affinity of DNA polymerase β delta palm thumb to the DNA 
substrate with increasing DNA polymerase β delta palm thumb amounts 
used.  
 
 
5.8 DNA polymerase β ’s binding to DNA is enhanced in 
presence of the 9-1-1 complex 
 
In order to confirm the stimulative effect of the 9-1-1 complex on DNA 
polymerase β’s ability to bind to its DNA substrate, EMSA’s with a titration of the 9-
1-1 complex in increasing amounts into a constant amount of DNA polymerase β wild 
type and its mutants (chosen according to the titrations in Figure 7) were performed. 
First, a titration of the 9-1-1 complex only in the amounts used later on in the assays 
was done, to confirm that the 9-1-1 complex alone does not induce any DNA 
bandshifting (Figure 8, panel A). By using 35 fmol of the DNA polymerase β wild 
type and titrating in the 9-1-1 complex, the stimulative effect of the 9-1-1 complex on 
DNA polymerase β wild type’s binding to DNA could clearly be confirmed by seeing 
an enhanced intensity of the DNA bandshift with increasing ratios of the 9-1-1 
complex (Figure 8, panel B), resulting from enhanced binding of DNA polymerase β 
wild type to DNA. A band that is even higher than the primary bandshift was 
appearing, indicating that an additional complex might have been formed. 
 By using the same molar 9-1-1 complex : DNA polymerase β ratios for the 
deletion mutants, only the stimulative effect of the 9-1-1 complex on the two mutants 
DNA polymerase β delta thumb and DNA polymerase β delta palm thumb could be 
tested, due to the very weak binding ability to DNA of the DNA polymerase β delta 
lyase mutant (see Figure 7, panel D). The use of such high amounts of protein 
(namely the 9-1-1 complex and the DNA polymerase β delta lyase) to do the titration 
in a similar ratio as for the other 2 mutants would have given not more than an unclear 
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smear of proteins on the gel without any possibility to draw conclusions from such 
results. Therefore the stimulation of this activity could not be tested for the DNA 
polymerase β delta lyase mutant. 
For the DNA polymerase β delta palm thumb mutant, a weak, but still visible 
increasing DNA bandshift was observed, correlating to the increasing amount of the 
9-1-1 complex used in the assay (Figure 8, panel C). This was a surprising result, as 
the immunoprecipitation of DNA polymerase β delta palm thumb by the 9-1-1 
complex never showed any interaction. Still, this mutants’ binding to DNA could be 
weakly stimulated, suggesting, that a possible weaker interaction site of the 9-1-1 
complex with the DNA polymerase β might exist on the palm subunit as well. 
For the DNA polymerase β delta thumb mutant, however, a good quality picture 
to show the increase of DNA bandshift could never be produced. This was likely due 
to the fact, that the shifted band migrated too close to the template to be distinguished 
properly when reasonable amounts of this mutant were used. 
 
 
 
 
Figure 8: DNA polymerase β and its delta palm thumb mutants binding 
ability to DNA is enhanced in the presence of the 9-1-1 complex 
An Electrophoresis mobility shift assay was performed with DNA 
polymerase β wild type and delta palm thumb mutant to detect increased 
binding to DNA in presence of the 9-1-1 complex. (A) A titration of 
increasing amounts of the 9-1-1 complex to 50 fmol of DNA template was 
performed to exclude any bandshift due to the 9-1-1 complex alone. The 
amounts that were tested here were used later on in the titrations for DNA 
polymerase β wild type and, with exception of the highest amount, also for 
the delta palm thumb mutant. The no enzyme control shows the reaction 
mix only without addition of the 9-1-1 complex. Lanes 1-3: 0.5, 1 and 2 
nmol of 9-1-1 complex, respectively. (B) Titration of the 9-1-1 complex in 
increasing amounts into 35 fmol of DNA polymerase β wild type and 50 
fmol of DNA template. Lanes 1-3 show the following ratios of 9-1-1 
complex : DNA polymerase β wild type: 15, 30, 60. A clear enhancement of 
the DNA bandshift can be observed on addition of increasing amounts of 
the 9-1-1 complex. DNA polymerase β only shows the bandshift induced 
without addition of 9-1-1 complex. (C) A titration of the 9-1-1 complex in 
increasing amounts into 100 fmol of DNA polymerase β delta palm thumb 
 Page 39 of 56 
and 50 fmol of DNA substrate. Polβ Δ PT only shows the bandshift induced 
without addition of 9-1-1 complex. Lanes 1and 2 show the  following ratios 
of 9-1-1 complex : DNA polymerase β wild type: 15 and 30. A slight DNA 
bandshift can be observed with increasing amounts of the 9-1-1 complex.  
 
5.9 Putative binding motif(s) of for the 9-1-1 complex on DNA 
polymerase β  
 
Taken together the facts that a binding site for the 9-1-1 complex is existing on 
the C-terminal part (amino acids 360-380) of Fen1 [36], on human DNA ligase I [45] 
and on Rad-17 [32] as well as on DNA polymerase β [35], the next aim was to look 
for a common possible specific binding motif present on these four proteins. An 
alignment of sequences of human DNA ligase I, DNA polymerase β (finger and palm 
domain), Rad17 and Fen1 (N-terminal part, amino acids 360-380), was performed, by 
using the ClustalW program for protein sequence alignment from the European 
Bioinformatics Institute. After the detection of putative conserved sequences, APE1 
as a further putative 9-1-1 complex binding partner was also tested for the presence of 
such a site. The results were the following: 
 
- DNA polymerase β, Fen1, Rad17 and APE1 share a sequence of mainly 6 
amino acids, that show a conserved glycine and other highly conserved or semi-
conserved amino acids (Figure 9, sequence coloured cyan). 
- DNA ligase I, DNA polymerase β, Rad17, APE1 and Fen1 share a sequence 
of again 6 amino acids, displaying high conservation of the amino acids (Figure 
9, sequence coloured blue). 
- DNA polymerase β, Fen1, Rad17, DNA ligase I and APE1 display a sequence 
of 8 amino acids, that are conserved to a wide extent. (Figure 9, sequence 
coloured pink) 
 
It is interesting, that for Fen1 the first (cyan) and the second (blue) motif are 
partly overlapping, possibly forming a single binding site. This is also the case for 
APE1, in which the first (cyan) sequence incorporates completely the second (blue) 
sequence. Furthermore one could argue that the probability of finding a novel 9-1-1 
interaction partner in APE1 is quite high. 
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Figure 9: Sequence alignment showing amino acids 141 – 190 of DNA 
polymerase β, aligned to the putative conserved sequences of Fen1, Rad17, 
DNA ligase I and APE1 showing possible 9-1-1 complex binding motifs. A 
“+” indicates that there are several amino acids present in the sequence, 
which are not displayed, presumably forming loop-like structures outside 
of the binding motiv. A “*” indicates indentical amino acids, a “:” shows 
highly conserved amino acids and a “.” points out semiconserved 
substitutions (more information to this classification available on the 
website of the European Bioinformatics Institute) The amino acids marked 
in bold show the amino acids in the different sequences that are identical to 
the DNA polymerase β sequence. (CYAN) This first putative binding motif 
is conserved on DNA polymerase β (AA 144 – 149), Fen1 (AA 362 – 367), 
Rad17 (AA 471 – 476) and APE1 (AA 178 – 187). (BLUE) The second 
putative binding motif is located on DNA polymerase β (AA 166 – 171), 
Fen1 (AA 364 – 369), Rad17 (AA 115-120), DNA ligase I (AA 239 – 244) 
and APE1 (AA 180 - 185) (PINK). This third conserved sequence can be 
found on DNA polymerase β (AA 177 – 184), Fen1 (AA 372 – 379), Rad17 
(AA 503 – 515),  DNA ligase I (AA 447 – 457)  and on APE1 (220 – 225). 
  
 
 
The existence of 2 or 3 putative binding motifs for the 9-1-1 complex on all the 
proteins known or believed to interact with the 9-1-1 complex is exciting, as for 
example Fen1 and DNA polymerase β, which obviously display all the three binding 
motifs, have been shown to interact with all the 3 subunits of the 9-1-1 complex. This 
existence of 3 binding motifs would be an explanation that all the 3 subunits can bind, 
as they do not dispose of consensus sequences, which rules out most probably a single 
binding site for all the 3 subunits together.   
 
 
Pol!   KYFG-DFEKRIPREEMLQMQDIVLNEVKKVDSEYIATVC-G-S-FR-RG 190
Fen1   ---G-STKKK--           ---TKKKAK--  -AA-G-K-FK-RG
Rad17  ---G-DWNTR--           ---PKQGGS--  --C+G+S-FR+RG
LigI   ------------           ---VKKEVK--  --S-G-R-LR-LG
APE1   ---G+EYRQR--           ---VRLEYR--  --------LR+KG
          * .:..:                .**  .     :. * . :: :*_
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5.10 The three putative 9-1-1 complex binding motifs are 
located on the outer surface of DNA polymerase β  and DNA 
ligase I  
 
The three putative binding motifs were tested for their location on the structural 
model of DNA polymerase β, on DNA ligase 1 and on APE1, respectively. 
Unfortunately, for Rad17 there is no structure model existing yet, and for Fen1, none 
including the last 20 amino acids, which are the relevant part for the interaction with 
the 9-1-1 complex. Therefore those two highly interesting proteins could not be 
investigated for structural location of those sites. However, the structural investigation 
of DNA polymerase β wild type revealed, that the three motifs are located closely to 
each other on the outer surface of the protein (Figure 10, panel A; the coloured motifs 
are also pointed at with an arrow). Moreover, they seem to be orientated towards the 
side of the protein, where the DNA, which is encircled by DNA polymerase β, leaves 
the protein. This seems to be a logical location for a binding site, as the 9-1-1 
complex closes around the DNA as a ring, probably giving the recruited proteins the 
opportunity to attach to it near the DNA passing through the ring, as depicted 
schematically on Figure 12. For DNA ligase I, a similar observation could be made 
(Figure 10, panel B). The putative two binding motifs are located on the same face of 
the DNA ligase I as on the DNA polymerase β, always close to the site, where the 
DNA strand leaves the protein. Finally, APE1 seems to display a location of the 
motifs very much like DNA polymerase β and DNA ligase I (Figure 10, panel C). 
Here the blue, second motif is not coloured specifically, as it is located in the middle 
of the cyan, first motif, and therefore is already covered by the cyan colouring.  
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Figure 10: Putative 9-1-1 complex binding motifs on DNA polymerase β 
(A), DNA ligase I (B) and APE1 (C). (A) DNA polymerase β wild type 
displays the putative binding motifs on its outer surface and in close 
proximity to each other. The motifs are located very closely to the surface 
on which the DNA strand that is bound leaves the protein. The sequences 
are coloured according to the alignment in Figure 9.  (B) DNA ligase I 
crystal structure with the putative binding motifs coloured according to the 
alignment in Figure 9. The location of the motifs is close to the side of the 
protein, where the DNA strand, that is bound, leaves the protein again. (C) 
APE1 structural model with coloured putative binding motifs, according to 
Figure 9.  
 
 
To conclude the investigations so far, it was finally interesting to see, how the 
distribution of those putative 9-1-1 complex binding motifs compares to the known 
PCNA binding motifs (reviewed in [50]). Figure 11 shows a schematic representation 
of the five proteins. In all the cases where a PCNA binding motif was identified 
(DNA polymerase β, DNA ligase I and  Fen1) the PCNA binding motif is located on 
at different site suggesting that the two clamps (PCNA and the 9-1-1 complex bind to 
different site on their partners. These motifs are now the bases to carry out site 
directed deletion mutagenesis to find out whether proteins binding to 9-1-1 complex  
also have a common motif to bind to their partners. 
 
 
 
 
Figure 11: Schematic presentation of the location of the known PCNA 
binding motif and the putative 9-1-1 complex binding motifs on DNA 
polymerase β, DNA ligase I, Rad17, Fen1 and APE1. The sequences refer 
all to human proteins. The colours for the 9-1-1 complex binding motifs are 
DNA Pol! 
DNA Ligase I
Rad17
Fen1
APE1
PCNA binding motif
Legend:
Putative 9-1-1 binding motif 1
Putative 9-1-1 binding motif 2
Putative 9-1-1 binding motif 3
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Distribution of binding motifs
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correlating to the coloured sequences in Figure 9 and all the colour codes 
used are indicated in the figure legend. The sequences are depicted in 
approximate length correlation to each other and the motifs are placed on 
the sequences in approximate spatial distribution.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 12: Proposed mechanism of Rad1, Rad9, Hus1 and Rad17 action in 
response to DNA damage. The DNA intermediate contains an unrepaired 
damaged site, (denoted by a bulge in the lower strand), that initiates 
translocation of Rad17 throughout the nucleus. Conversion of RFC1–5 to 
Rad17/RFC2–5 is required for ATP-dependent loading of the 
Rad1/Rad9/Hus1 heterotrimeric ring onto DNA. Repair synthesis can then 
proceed by (for example) a lesion bypass polymerase that utilizes the 
heterotrimeric ring for more efficient and/or accurate synthesis. 
(Reproduction from: “Structure-based predictions of Rad1, Rad9, Hus1 
and Rad17 participation in sliding clamp and clamp-loading complexes”, 
C. Venclovas and M. P. Thelen, [27]) 
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6 Discussion 
 
The 9-1-1 complex has been shown to be recruited onto DNA following DNA 
damage as an early step of the checkpoint cascades [52]. Its structural similarity to 
PCNA suggested that it might act as an alternative sliding clamp for certain DNA 
polymerases, such as repair or translesion DNA polymerases (Figure 12), [25-28]. 
Recent data suggested that the 9-1-1 complex may play a role in recruitment of 
proteins involved in BER [33,34]. The aim of this thesis was to analyse in details the 
interaction of the 9-1-1 complex with the two BER proteins DNA polymerase β and 
DNA ligase I.  
A first step in this work was to characterise the DNA polymerase β mutants 
used for the interaction studies. This characterisation led to several interesting 
findings. For the delta lyase mutant it was astonishing to see that, even though it 
contained the full part of the polymerase domain which is shown to be responsible for 
the entire polymerisation process on DNA templates, it seems to be hardly able to 
polymerise longer products than approximately 9 nucleotides. This observation is in 
strong contrast to the fact, that the wild type protein in a 200 fold smaller amount 
elongates easily the entire template strand. It seems, that the lacking lyase part of the 
protein is very important for mediation of the binding to DNA, which, when not 
present, causes a decrease in DNA polymerase β’s affinity to the DNA template. 
Since the intensity of the signal of the accumulated small products seems to be much 
higher than the one compared to the other mutants that have conserved their 
processivity, it can be concluded that the polymerase-activity per se is not hindered or 
diminished.  Obviously this mutant has lost its ability to bind properly to the DNA 
and may stay attached to it, which is a major issue when regarding the processivity of 
DNA polymerase β. Further evidence for this is also provided by the fact, that in 
DNA-binding experiments with EMSA, a minimal 150 fold higher amount of DNA 
polymerase β delta lyase compared to the other mutants had to be used to be able to 
observe any significant bandshift.  
Other observations concern the two polymerase-domain mutants, which were 
initially not expected to be as active as observed in the activity assays. Specially the 
activity of the DNA polymerase β delta thumb mutant was quite astonishing, while 
the fact, that the DNA polymerase β delta palm thumb mutant, lacking the catalytic 
site for polymerase activity, showed polymerase activity as well can most probably be 
explained by a contamination of this batch of protein by E.coli DNA polymerases. It 
would be of great interest to test the DNA polymerase β delta thumb mutant for its 
mismatch incorporation activity, as it has been shown, that the thumb domain is 
responsible for correct nucleotide pairing by shifting the protein from an ‘open’ 
conformation to a ‘closed’ one, when the correct nucleotide to be incorporated is 
present [51]. It could be, that the delta thumb mutant incorporates just randomly 
nucleotides on the growing DNA strand, no matter what nucleotide is located opposite 
the incorporation site. 
The comparison between the physical and functional interaction of the 9-1-1 
complex with DNA polymerase β and its deletion mutants yielded to some rather 
puzzling results. After obtaining the results from the immunoprecipitation assays, that 
the 9-1-1 complex interacted with the palm subdomain, the question about the binding 
site of the 9-1-1 complex to DNA polymerase β seemed to be quite clearly answered. 
In all the repetitions of this assay, an interaction between the delta palm thumb mutant 
and the 9-1-1 complex could never be observed, while the 9-1-1 complex could be 
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immunoprecipitated by the other two mutants and the wild type protein. Nevertheless, 
the data received from the DNA-binding stimulation assays with EMSA’s seemed to 
contradict the immunoprecipitation data. Here it became obvious, that all of the tested 
mutants, including the delta palm thumb mutant, could be stimulated by the 9-1-1 
complex specifically, even though in lower range. To explain this, the idea of multiple 
different binding sites of the 9-1-1 complex on the DNA polymerase β, of which a 
stronger one is located on the palm domain and another weaker one is located on the 
finger domain, was proposed. Our hypothesis was that, if the stronger interaction site 
is not present anymore in the protein (which would be then the case when using the 
palm thumb mutant), the interaction is probably more transient and cannot necessarily 
be detected in the immunoprecipitation experiments. However, the binding of the 9-1-
1 complex to the weaker interaction motif could still be strong enough to stimulate 
DNA polymerase β’s DNA binding activity. Another hint towards this hypothesis 
was, that the bandshift caused by the 9-1-1 complex to the delta palm thumb mutant 
seems to be much weaker than the one observed in the wild type, not perfectly 
explainable only by the lower activity of DNA binding of this mutant. The existence 
of such multiple binding sites would explain both, a loss of interaction when 
immunoprecipitating DNA polymerase β delta palm thumb by the 9-1-1 complex 
through the loss of the strongly interacting binding motif, but a conserved stimulating 
influence on the DNA binding activity via the weaker and less conserved interaction 
motif. To investigate this possibility, a sequence alignment was performed, comparing 
the sequences of the five 9-1-1 complex binding proteins DNA ligase 1, DNA 
polymerase β (fingers and palm domain), Fen1 (N-terminal part consisting of the last 
20 amino acids, shown to be the part interacting with the 9-1-1 complex [36]), APE 1 
(as putative partner for the 9-1-1 complex) and Rad17. The data obtained from the 
sequence alignment showed three conserved putative binding motifs, with two of 
them located on the palm domain and a third one located on the finger domain. 
These findings were then combined with structural analysis of the crystal 
structure of DNA polymerase β, DNA ligase I and APE1, in order to see where those 
putative interaction sites were located on the proteins. It was evident, that the 
predicted putative 9-1-1 complex binding sites found by sequence alignment are 
located on exposed areas of the outer surface of each of the proteins, and therefore 
also easily accessible to other proteins. The sequences were then compared further to 
the location the PCNA binding motif, and in none observed cases they overlapped.  
In conclusion, in order to further investigate those possible interaction sites, it 
would be necessary to perform site-directed mutagenesis. By mutating important 
amino acids placed within a relevant binding motif, a loss of interaction could be 
observed, which would confirm the physiological relevance of those so far putative 
interaction motifs.  
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My contribution to this work was the physical interaction study between DNA ligase I 
and the 9-1-1 complex and is represented in Figure 1 of this paper. 
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